Venous Thromboembolism in Orthopedic Surgical Patients:
Guideline Directed Prophylaxis Therapy

Credit Area For Credit: Register/Login     View Activity As Guest

Release Date: Dec 15, 2014          Expiration Date: Dec 15, 2015

By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.

Program Description

Orthopedic surgeons and their team of health care providers need to understand the impact of venous thromboembolism (VTE) and become more familiar with guideline recommendations for VTE prophylaxis, in order to provide appropriate and adequate management to their orthopedic surgery patients. This enduring activity is designed to provide clinicians who care for surgical patients undergoing total knee or total hip arthroscopy with the latest clinical evidence surrounding pharmacologic interventions for preventing new onset and recurrent deep vein thrombosis (DVT)/VTE, including the current rationales for using heparin and/or warfarin vs newer antithrombotic agents. The proposed activity will also explore the optimization of post-discharge treatments and discuss the importance of educating patients on adherence to prescribed prophylactic treatments to avoid future DVT/VTE events.


Richard J. Friedman, MD, FRCSC - Chair
Chief, Shoulder and Elbow Surgery
Professor of Orthopedics
Medical University of South Carolina
Charleston, SC

Read Biography

Kenneth A. Bauer, MD
Professor of Medicine
Harvard Medical School
Boston, MA

Read Biography

Scott Kaatz, DO, MSc, FACP, FHM
Chief Quality Officer
Hurley Medical Center
Flint, MI

Read Biography

Target Audience

This activity is intended for orthopedic surgeons, orthopedic nurses, and physician assistants involved in the management and care of their surgical patients.

Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Discuss major orthopedic surgery as an important risk factor for the development of deep vein thrombosis (DVT), which can lead to venous thromboembolism (VTE) and life-threatening pulmonary embolism
  • Analyze current treatment options for prophylaxis of DVT and their therapeutic limitations, which can undermine patient adherence and increase the risk of thromboembolic events
  • Discuss how optimal management of patients undergoing major orthopedic surgery requires the coordinated efforts of orthopedic surgeons, orthopedic nurses, physician assistants, and clinical pharmacists working in concert to prevent thromboembolic complications
  • Develop strategies to incorporate into practice physician quality reporting systems, performance improvement measures, and clinical practice guidelines to improve quality of care and decrease the risk of recurrent events and rehospitalization in orthopedic surgical patients at risk for VTE


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Rockpointe Corporation.

The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.


The University of Cincinnati designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.


University of Cincinnati adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by the University of Cincinnati are required to disclose any relevant financial relationships with any commercial interest to University of Cincinnati as well as to learners. All conflicts are identified and resolved by University of Cincinnati in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

The faculty and steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Kenneth A. Bauer, MD: Advisory board: Bristol-Myers Squibb, Daiichi-Sankyo, Pfizer; Consultant: Green Cross Corporation, Instrumentation Laboratory; Data Safety Monitoring Board: Janssen Pharmaceuticals

Richard J. Friedman, MD, FRCSC: Consultant: Exactech; Grant recipient: Exactech, Tornier

Scott Kaatz, DO, MSc, FACP, FHM: Advisory board:  Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Daiichi-Sankyo, Janssen; Consultant: Janssen; Speaker's Bureau: Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Janssen Pharmaceuticals

Non-faculty Disclosures
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Barry Watkins, PhD; Blair St. Amand; Jay Katz, CCMEP; Rick Ricer, MD: Nothing to disclose

FDA Disclosure

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

System Requirements

In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can be downloaded here.


There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test and evaluation. To complete the evaluation online, choose the best answer to each question. The estimated time for completion of this activity is 2.0 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test three times.


University of Cincinnati and Rockpointe

Supported By

Supported by an educational grant from Bristol-Myers Squibb and Pfizer, Inc. Alliance

By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.